免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study

NCT:NCT06172699 · COMPLETED

NCT IDNCT06172699
狀態COMPLETED
開始日期2024-01-01
完成時間2025-11-10
SponsorAbbott Medical Devices (INDUSTRY)
First posted
Last updated

簡要摘要

This is a prospective, non-randomized, multi-center, real-world post-market study to collect and evaluate data regarding the performance of the enhanced atrial fibrillation detection algorithm of the Assert-IQTM Implantable Cardiac Monitor (ICM) device.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑